Table 1 Baseline characteristics of participants, n = 16

N

16

Gender (male / female)

14 / 2

Lipid lowering medication (statins / no therapy)

10 / 6

Age (y)

62 ± 6.9

Diabetes duration (y)

6.6 ± 4.6

Body weight (kg)

94 ± 17

BMI (kg/m²)

30 ± 4.4

HbA1c (mmol/mol)

50 ± 9.2

Fasting plasma glucose (mmol/L)

8.2 ± 2.0

Fat mass (kg)

32 ± 9.2

Fat free mass (kg)

62 ± 10

TEE¹ (MJ/day)

10 ± 1.4

HOMA2-IR²

2.4 ± 1.0